Sensus Healthcare Reports Significant 2025 Loss, 34% Revenue Decline, and Credit Covenant Default
summarizeSummary
Sensus Healthcare reported a 34% revenue decrease and a $7.7 million net loss for 2025, leading to a default on a credit facility profitability covenant, alongside ongoing customer concentration and a DOJ investigation.
check_boxKey Events
-
Significant Financial Decline
Revenue decreased by 34% to $27.5 million in 2025 from $41.8 million in 2024. The company swung to a net loss of $7.7 million in 2025, compared to a net income of $6.6 million in 2024.
-
Credit Facility Covenant Default
As of December 31, 2025, Sensus Healthcare was in default under its $15 million revolving credit facility for failing to maintain the required minimum profitability covenant.
-
High Customer Concentration
One U.S. customer accounted for 52% of the company's revenue in 2025 and 65% of its accounts receivable, indicating significant reliance on a single client.
-
Ongoing DOJ Investigation
The company is subject to a Civil Investigative Demand from the Department of Justice, initiated in August 2019, concerning Medicare billing practices by a physician using its SRT-100 product.
auto_awesomeAnalysis
Sensus Healthcare's annual report reveals a substantial deterioration in financial performance for fiscal year 2025, marked by a significant revenue decline and a swing to a net loss. The company's revenue decreased by 34% to $27.5 million, and it reported a net loss of $7.7 million, a sharp reversal from a $6.6 million net income in 2024. This downturn led to a default on a minimum profitability covenant under its $15 million revolving credit facility, raising concerns about its financial health despite management's assertion of sufficient liquidity for the next 12 months. The company also continues to face high customer concentration, with one U.S. customer accounting for 52% of its 2025 revenue. While new CPT codes effective January 2026 are anticipated to boost demand and new service offerings were launched, the immediate financial results and covenant breach present significant challenges.
At the time of this filing, SRTS was trading at $4.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $71.5M. The 52-week trading range was $3.03 to $5.92. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.